Imugene Limited ABN 99 009 179 551 www.imugene.com Suite 12.01, Level 12 4-6 Bligh Street Sydney NSW 2000 AUSTRALIA 9 October 2026 Upcoming Annual General Meeting of Shareholders Dear Shareholder, Imugene Limited ACN 009 179 551 (ASX: IMU or “the Company”), advises that an...
Imugene: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 52 pages · English
Release
Story so far
Earlier from Imugene
- Dr John Le Gall appointed Chief Medical Officer
- azer-cel BTKi Cohort Reports new Complete & Partial Response
- Change of Director's Interest Notice - JD
- Application for quotation of securities - IMU
- Cleansing Notice
Later from Imugene
- Notification of cessation of securities - IMU
- Further Responses in azer-cel Phase 1b Trial
- Quarterly Activities/Appendix 4C Cash Flow Report
- Positive amendments to Convertible Notes
- Imugene selected for Poster Presentation at 2026 ASH Meeting
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene